Hospira Methotrexate Injection USP 1g/40mL vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

methotrexate, Quantity: 25 mg/mL

Available from:

Hospira Australia Pty Ltd

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride

Administration route:

Intravenous, Intraarterial, Intramuscular, Intrathecal

Units in package:

1x40mL vial

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Methotrexate Injection USP belongs to a group of medicines known as anti-metabolites. It is used in high doses to treat certain types of cancers, including breast cancer, Non-Hodgkin's lymphoma and leukemia. At lower doses, it may also be used to treat sever psoriasis and severe rheumatoid arthritis.

Product summary:

Visual Identification: A clear yellow solution. Free from visible particulates.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Listed (Export Only)

Authorization date:

1992-06-02